New insider activity at Thermo Fisher ( (TMO) ) has taken place on December 5, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EVP & COO Michel Lagarde recently sold 22,046 shares of Thermo Fisher stock, amounting to a total transaction value of $12,424,243.
Recent Updates on TMO stock
In the last 24 hours, Thermo Fisher’s stock has seen significant analyst activity, with Morgan Stanley assuming coverage with an Overweight rating and a price target increase to $670, citing emerging bright spots in the Life Science Tools and Diagnostics market and numerous catalysts in the pipeline. HSBC also upgraded Thermo Fisher to Buy from Hold, aligning with the $670 price target. These changes reflect optimism about the company’s strategic positioning and growth prospects, particularly with recent industry developments and acquisitions enhancing its market offerings.
Spark’s Take on TMO Stock
According to Spark, TipRanks’ AI Analyst, TMO is a Outperform.
Thermo Fisher’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust profitability and strategic initiatives, such as collaborations and acquisitions, support its growth outlook. However, technical indicators suggest the stock may be overbought, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
To see Spark’s full report on TMO stock, click here.
More about Thermo Fisher
YTD Price Performance: 10.88%
Average Trading Volume: 2,056,622
Technical Sentiment Signal: Strong Buy
Current Market Cap: $216.1B